nodes	percent_of_prediction	percent_of_DWPC	metapath
Duloxetine—Weight increased—Zoledronate—Paget's disease of bone	0.00232	0.00232	CcSEcCtD
Duloxetine—Oedema peripheral—Risedronate—Paget's disease of bone	0.00232	0.00232	CcSEcCtD
Duloxetine—Connective tissue disorder—Risedronate—Paget's disease of bone	0.00231	0.00231	CcSEcCtD
Duloxetine—Weight decreased—Zoledronate—Paget's disease of bone	0.00231	0.00231	CcSEcCtD
Duloxetine—Urethral disorder—Risedronate—Paget's disease of bone	0.00231	0.00231	CcSEcCtD
Duloxetine—Malaise—Alendronate—Paget's disease of bone	0.0023	0.0023	CcSEcCtD
Duloxetine—Vertigo—Alendronate—Paget's disease of bone	0.00229	0.00229	CcSEcCtD
Duloxetine—Infestation NOS—Zoledronate—Paget's disease of bone	0.00228	0.00228	CcSEcCtD
Duloxetine—Infestation—Zoledronate—Paget's disease of bone	0.00228	0.00228	CcSEcCtD
Duloxetine—Haemoglobin—Pamidronate—Paget's disease of bone	0.00225	0.00225	CcSEcCtD
Duloxetine—Renal failure—Zoledronate—Paget's disease of bone	0.00224	0.00224	CcSEcCtD
Duloxetine—Haemorrhage—Pamidronate—Paget's disease of bone	0.00224	0.00224	CcSEcCtD
Duloxetine—Musculoskeletal discomfort—Etidronic acid—Paget's disease of bone	0.00223	0.00223	CcSEcCtD
Duloxetine—Stomatitis—Zoledronate—Paget's disease of bone	0.00222	0.00222	CcSEcCtD
Duloxetine—Urinary tract infection—Zoledronate—Paget's disease of bone	0.00221	0.00221	CcSEcCtD
Duloxetine—Conjunctivitis—Zoledronate—Paget's disease of bone	0.00221	0.00221	CcSEcCtD
Duloxetine—Urinary tract disorder—Pamidronate—Paget's disease of bone	0.00221	0.00221	CcSEcCtD
Duloxetine—Eye disorder—Risedronate—Paget's disease of bone	0.0022	0.0022	CcSEcCtD
Duloxetine—Connective tissue disorder—Pamidronate—Paget's disease of bone	0.0022	0.0022	CcSEcCtD
Duloxetine—Paraesthesia—Etidronic acid—Paget's disease of bone	0.0022	0.0022	CcSEcCtD
Duloxetine—Tinnitus—Risedronate—Paget's disease of bone	0.00219	0.00219	CcSEcCtD
Duloxetine—Urethral disorder—Pamidronate—Paget's disease of bone	0.00219	0.00219	CcSEcCtD
Duloxetine—Cardiac disorder—Risedronate—Paget's disease of bone	0.00218	0.00218	CcSEcCtD
Duloxetine—Chest pain—Alendronate—Paget's disease of bone	0.00217	0.00217	CcSEcCtD
Duloxetine—Myalgia—Alendronate—Paget's disease of bone	0.00217	0.00217	CcSEcCtD
Duloxetine—Dyspepsia—Etidronic acid—Paget's disease of bone	0.00215	0.00215	CcSEcCtD
Duloxetine—Discomfort—Alendronate—Paget's disease of bone	0.00215	0.00215	CcSEcCtD
Duloxetine—Angiopathy—Risedronate—Paget's disease of bone	0.00214	0.00214	CcSEcCtD
Duloxetine—Immune system disorder—Risedronate—Paget's disease of bone	0.00213	0.00213	CcSEcCtD
Duloxetine—Mediastinal disorder—Risedronate—Paget's disease of bone	0.00212	0.00212	CcSEcCtD
Duloxetine—Arrhythmia—Risedronate—Paget's disease of bone	0.0021	0.0021	CcSEcCtD
Duloxetine—Constipation—Etidronic acid—Paget's disease of bone	0.00209	0.00209	CcSEcCtD
Duloxetine—Eye disorder—Pamidronate—Paget's disease of bone	0.00209	0.00209	CcSEcCtD
Duloxetine—Flushing—Pamidronate—Paget's disease of bone	0.00208	0.00208	CcSEcCtD
Duloxetine—Cardiac disorder—Pamidronate—Paget's disease of bone	0.00208	0.00208	CcSEcCtD
Duloxetine—Infection—Alendronate—Paget's disease of bone	0.00207	0.00207	CcSEcCtD
Duloxetine—Mental disorder—Risedronate—Paget's disease of bone	0.00206	0.00206	CcSEcCtD
Duloxetine—Malnutrition—Risedronate—Paget's disease of bone	0.00205	0.00205	CcSEcCtD
Duloxetine—Hypoaesthesia—Zoledronate—Paget's disease of bone	0.00203	0.00203	CcSEcCtD
Duloxetine—Angiopathy—Pamidronate—Paget's disease of bone	0.00203	0.00203	CcSEcCtD
Duloxetine—Immune system disorder—Pamidronate—Paget's disease of bone	0.00202	0.00202	CcSEcCtD
Duloxetine—Flatulence—Risedronate—Paget's disease of bone	0.00202	0.00202	CcSEcCtD
Duloxetine—Urinary tract disorder—Zoledronate—Paget's disease of bone	0.00202	0.00202	CcSEcCtD
Duloxetine—Mediastinal disorder—Pamidronate—Paget's disease of bone	0.00202	0.00202	CcSEcCtD
Duloxetine—Feeling abnormal—Etidronic acid—Paget's disease of bone	0.00202	0.00202	CcSEcCtD
Duloxetine—Oedema peripheral—Zoledronate—Paget's disease of bone	0.00201	0.00201	CcSEcCtD
Duloxetine—Connective tissue disorder—Zoledronate—Paget's disease of bone	0.00201	0.00201	CcSEcCtD
Duloxetine—Chills—Pamidronate—Paget's disease of bone	0.00201	0.00201	CcSEcCtD
Duloxetine—Urethral disorder—Zoledronate—Paget's disease of bone	0.002	0.002	CcSEcCtD
Duloxetine—Gastrointestinal pain—Etidronic acid—Paget's disease of bone	0.002	0.002	CcSEcCtD
Duloxetine—Back pain—Risedronate—Paget's disease of bone	0.00198	0.00198	CcSEcCtD
Duloxetine—Alopecia—Pamidronate—Paget's disease of bone	0.00198	0.00198	CcSEcCtD
Duloxetine—Muscle spasms—Risedronate—Paget's disease of bone	0.00197	0.00197	CcSEcCtD
Duloxetine—Malnutrition—Pamidronate—Paget's disease of bone	0.00195	0.00195	CcSEcCtD
Duloxetine—Erythema—Pamidronate—Paget's disease of bone	0.00195	0.00195	CcSEcCtD
Duloxetine—Urticaria—Etidronic acid—Paget's disease of bone	0.00194	0.00194	CcSEcCtD
Duloxetine—Abdominal pain—Etidronic acid—Paget's disease of bone	0.00193	0.00193	CcSEcCtD
Duloxetine—Tension—Pamidronate—Paget's disease of bone	0.00191	0.00191	CcSEcCtD
Duloxetine—Eye disorder—Zoledronate—Paget's disease of bone	0.00191	0.00191	CcSEcCtD
Duloxetine—Dysgeusia—Pamidronate—Paget's disease of bone	0.00191	0.00191	CcSEcCtD
Duloxetine—Musculoskeletal discomfort—Alendronate—Paget's disease of bone	0.0019	0.0019	CcSEcCtD
Duloxetine—Cardiac disorder—Zoledronate—Paget's disease of bone	0.0019	0.0019	CcSEcCtD
Duloxetine—Flushing—Zoledronate—Paget's disease of bone	0.0019	0.0019	CcSEcCtD
Duloxetine—Anaemia—Risedronate—Paget's disease of bone	0.00189	0.00189	CcSEcCtD
Duloxetine—Nervousness—Pamidronate—Paget's disease of bone	0.00189	0.00189	CcSEcCtD
Duloxetine—Back pain—Pamidronate—Paget's disease of bone	0.00188	0.00188	CcSEcCtD
Duloxetine—Muscle spasms—Pamidronate—Paget's disease of bone	0.00187	0.00187	CcSEcCtD
Duloxetine—Angioedema—Risedronate—Paget's disease of bone	0.00187	0.00187	CcSEcCtD
Duloxetine—Angiopathy—Zoledronate—Paget's disease of bone	0.00185	0.00185	CcSEcCtD
Duloxetine—Immune system disorder—Zoledronate—Paget's disease of bone	0.00185	0.00185	CcSEcCtD
Duloxetine—Mediastinal disorder—Zoledronate—Paget's disease of bone	0.00184	0.00184	CcSEcCtD
Duloxetine—Vertigo—Risedronate—Paget's disease of bone	0.00184	0.00184	CcSEcCtD
Duloxetine—Syncope—Risedronate—Paget's disease of bone	0.00184	0.00184	CcSEcCtD
Duloxetine—Dyspepsia—Alendronate—Paget's disease of bone	0.00183	0.00183	CcSEcCtD
Duloxetine—Chills—Zoledronate—Paget's disease of bone	0.00183	0.00183	CcSEcCtD
Duloxetine—Arrhythmia—Zoledronate—Paget's disease of bone	0.00183	0.00183	CcSEcCtD
Duloxetine—Ill-defined disorder—Pamidronate—Paget's disease of bone	0.00181	0.00181	CcSEcCtD
Duloxetine—Alopecia—Zoledronate—Paget's disease of bone	0.00181	0.00181	CcSEcCtD
Duloxetine—Hypersensitivity—Etidronic acid—Paget's disease of bone	0.0018	0.0018	CcSEcCtD
Duloxetine—Loss of consciousness—Risedronate—Paget's disease of bone	0.0018	0.0018	CcSEcCtD
Duloxetine—Anaemia—Pamidronate—Paget's disease of bone	0.0018	0.0018	CcSEcCtD
Duloxetine—Mental disorder—Zoledronate—Paget's disease of bone	0.00179	0.00179	CcSEcCtD
Duloxetine—Agitation—Pamidronate—Paget's disease of bone	0.00179	0.00179	CcSEcCtD
Duloxetine—Cough—Risedronate—Paget's disease of bone	0.00179	0.00179	CcSEcCtD
Duloxetine—Pain—Alendronate—Paget's disease of bone	0.00178	0.00178	CcSEcCtD
Duloxetine—Constipation—Alendronate—Paget's disease of bone	0.00178	0.00178	CcSEcCtD
Duloxetine—Angioedema—Pamidronate—Paget's disease of bone	0.00178	0.00178	CcSEcCtD
Duloxetine—Erythema—Zoledronate—Paget's disease of bone	0.00178	0.00178	CcSEcCtD
Duloxetine—Malnutrition—Zoledronate—Paget's disease of bone	0.00178	0.00178	CcSEcCtD
Duloxetine—Hypertension—Risedronate—Paget's disease of bone	0.00177	0.00177	CcSEcCtD
Duloxetine—Malaise—Pamidronate—Paget's disease of bone	0.00176	0.00176	CcSEcCtD
Duloxetine—Syncope—Pamidronate—Paget's disease of bone	0.00175	0.00175	CcSEcCtD
Duloxetine—Arthralgia—Risedronate—Paget's disease of bone	0.00174	0.00174	CcSEcCtD
Duloxetine—Chest pain—Risedronate—Paget's disease of bone	0.00174	0.00174	CcSEcCtD
Duloxetine—Myalgia—Risedronate—Paget's disease of bone	0.00174	0.00174	CcSEcCtD
Duloxetine—Leukopenia—Pamidronate—Paget's disease of bone	0.00174	0.00174	CcSEcCtD
Duloxetine—Dysgeusia—Zoledronate—Paget's disease of bone	0.00174	0.00174	CcSEcCtD
Duloxetine—Anxiety—Risedronate—Paget's disease of bone	0.00174	0.00174	CcSEcCtD
Duloxetine—Unspecified disorder of skin and subcutaneous tissue—Risedronate—Paget's disease of bone	0.00173	0.00173	CcSEcCtD
Duloxetine—Pruritus—Etidronic acid—Paget's disease of bone	0.00173	0.00173	CcSEcCtD
Duloxetine—Back pain—Zoledronate—Paget's disease of bone	0.00172	0.00172	CcSEcCtD
Duloxetine—Feeling abnormal—Alendronate—Paget's disease of bone	0.00172	0.00172	CcSEcCtD
Duloxetine—Loss of consciousness—Pamidronate—Paget's disease of bone	0.00171	0.00171	CcSEcCtD
Duloxetine—Muscle spasms—Zoledronate—Paget's disease of bone	0.00171	0.00171	CcSEcCtD
Duloxetine—Dry mouth—Risedronate—Paget's disease of bone	0.00171	0.00171	CcSEcCtD
Duloxetine—Gastrointestinal pain—Alendronate—Paget's disease of bone	0.0017	0.0017	CcSEcCtD
Duloxetine—Cough—Pamidronate—Paget's disease of bone	0.0017	0.0017	CcSEcCtD
Duloxetine—Convulsion—Pamidronate—Paget's disease of bone	0.00169	0.00169	CcSEcCtD
Duloxetine—Hypertension—Pamidronate—Paget's disease of bone	0.00168	0.00168	CcSEcCtD
Duloxetine—Vision blurred—Zoledronate—Paget's disease of bone	0.00168	0.00168	CcSEcCtD
Duloxetine—Diarrhoea—Etidronic acid—Paget's disease of bone	0.00167	0.00167	CcSEcCtD
Duloxetine—Tremor—Zoledronate—Paget's disease of bone	0.00167	0.00167	CcSEcCtD
Duloxetine—Infection—Risedronate—Paget's disease of bone	0.00166	0.00166	CcSEcCtD
Duloxetine—Arthralgia—Pamidronate—Paget's disease of bone	0.00166	0.00166	CcSEcCtD
Duloxetine—Myalgia—Pamidronate—Paget's disease of bone	0.00166	0.00166	CcSEcCtD
Duloxetine—Urticaria—Alendronate—Paget's disease of bone	0.00166	0.00166	CcSEcCtD
Duloxetine—Anxiety—Pamidronate—Paget's disease of bone	0.00165	0.00165	CcSEcCtD
Duloxetine—Ill-defined disorder—Zoledronate—Paget's disease of bone	0.00165	0.00165	CcSEcCtD
Duloxetine—Abdominal pain—Alendronate—Paget's disease of bone	0.00165	0.00165	CcSEcCtD
Duloxetine—Body temperature increased—Alendronate—Paget's disease of bone	0.00165	0.00165	CcSEcCtD
Duloxetine—Shock—Risedronate—Paget's disease of bone	0.00165	0.00165	CcSEcCtD
Duloxetine—Anaemia—Zoledronate—Paget's disease of bone	0.00164	0.00164	CcSEcCtD
Duloxetine—Nervous system disorder—Risedronate—Paget's disease of bone	0.00164	0.00164	CcSEcCtD
Duloxetine—Discomfort—Pamidronate—Paget's disease of bone	0.00164	0.00164	CcSEcCtD
Duloxetine—Agitation—Zoledronate—Paget's disease of bone	0.00164	0.00164	CcSEcCtD
Duloxetine—Angioedema—Zoledronate—Paget's disease of bone	0.00163	0.00163	CcSEcCtD
Duloxetine—Skin disorder—Risedronate—Paget's disease of bone	0.00162	0.00162	CcSEcCtD
Duloxetine—Malaise—Zoledronate—Paget's disease of bone	0.0016	0.0016	CcSEcCtD
Duloxetine—Confusional state—Pamidronate—Paget's disease of bone	0.0016	0.0016	CcSEcCtD
Duloxetine—Vertigo—Zoledronate—Paget's disease of bone	0.0016	0.0016	CcSEcCtD
Duloxetine—Syncope—Zoledronate—Paget's disease of bone	0.0016	0.0016	CcSEcCtD
Duloxetine—Leukopenia—Zoledronate—Paget's disease of bone	0.00159	0.00159	CcSEcCtD
Duloxetine—Oedema—Pamidronate—Paget's disease of bone	0.00159	0.00159	CcSEcCtD
Duloxetine—Anaphylactic shock—Pamidronate—Paget's disease of bone	0.00159	0.00159	CcSEcCtD
Duloxetine—Infection—Pamidronate—Paget's disease of bone	0.00158	0.00158	CcSEcCtD
Duloxetine—Palpitations—Zoledronate—Paget's disease of bone	0.00157	0.00157	CcSEcCtD
Duloxetine—Shock—Pamidronate—Paget's disease of bone	0.00156	0.00156	CcSEcCtD
Duloxetine—Loss of consciousness—Zoledronate—Paget's disease of bone	0.00156	0.00156	CcSEcCtD
Duloxetine—Nervous system disorder—Pamidronate—Paget's disease of bone	0.00156	0.00156	CcSEcCtD
Duloxetine—Thrombocytopenia—Pamidronate—Paget's disease of bone	0.00156	0.00156	CcSEcCtD
Duloxetine—Vomiting—Etidronic acid—Paget's disease of bone	0.00156	0.00156	CcSEcCtD
Duloxetine—Cough—Zoledronate—Paget's disease of bone	0.00155	0.00155	CcSEcCtD
Duloxetine—Tachycardia—Pamidronate—Paget's disease of bone	0.00155	0.00155	CcSEcCtD
Duloxetine—Rash—Etidronic acid—Paget's disease of bone	0.00154	0.00154	CcSEcCtD
Duloxetine—Convulsion—Zoledronate—Paget's disease of bone	0.00154	0.00154	CcSEcCtD
Duloxetine—Dermatitis—Etidronic acid—Paget's disease of bone	0.00154	0.00154	CcSEcCtD
Duloxetine—Hyperhidrosis—Pamidronate—Paget's disease of bone	0.00154	0.00154	CcSEcCtD
Duloxetine—Hypertension—Zoledronate—Paget's disease of bone	0.00154	0.00154	CcSEcCtD
Duloxetine—Hypersensitivity—Alendronate—Paget's disease of bone	0.00154	0.00154	CcSEcCtD
Duloxetine—Headache—Etidronic acid—Paget's disease of bone	0.00153	0.00153	CcSEcCtD
Duloxetine—Musculoskeletal discomfort—Risedronate—Paget's disease of bone	0.00152	0.00152	CcSEcCtD
Duloxetine—Anorexia—Pamidronate—Paget's disease of bone	0.00152	0.00152	CcSEcCtD
Duloxetine—Myalgia—Zoledronate—Paget's disease of bone	0.00151	0.00151	CcSEcCtD
Duloxetine—Chest pain—Zoledronate—Paget's disease of bone	0.00151	0.00151	CcSEcCtD
Duloxetine—Arthralgia—Zoledronate—Paget's disease of bone	0.00151	0.00151	CcSEcCtD
Duloxetine—Insomnia—Risedronate—Paget's disease of bone	0.00151	0.00151	CcSEcCtD
Duloxetine—Anxiety—Zoledronate—Paget's disease of bone	0.00151	0.00151	CcSEcCtD
Duloxetine—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—Paget's disease of bone	0.0015	0.0015	CcSEcCtD
Duloxetine—Paraesthesia—Risedronate—Paget's disease of bone	0.0015	0.0015	CcSEcCtD
Duloxetine—Discomfort—Zoledronate—Paget's disease of bone	0.0015	0.0015	CcSEcCtD
Duloxetine—Asthenia—Alendronate—Paget's disease of bone	0.0015	0.0015	CcSEcCtD
Duloxetine—Dry mouth—Zoledronate—Paget's disease of bone	0.00148	0.00148	CcSEcCtD
Duloxetine—Pruritus—Alendronate—Paget's disease of bone	0.00147	0.00147	CcSEcCtD
Duloxetine—Dyspepsia—Risedronate—Paget's disease of bone	0.00147	0.00147	CcSEcCtD
Duloxetine—Confusional state—Zoledronate—Paget's disease of bone	0.00146	0.00146	CcSEcCtD
Duloxetine—Nausea—Etidronic acid—Paget's disease of bone	0.00145	0.00145	CcSEcCtD
Duloxetine—Anaphylactic shock—Zoledronate—Paget's disease of bone	0.00145	0.00145	CcSEcCtD
Duloxetine—Oedema—Zoledronate—Paget's disease of bone	0.00145	0.00145	CcSEcCtD
Duloxetine—Musculoskeletal discomfort—Pamidronate—Paget's disease of bone	0.00145	0.00145	CcSEcCtD
Duloxetine—Gastrointestinal disorder—Risedronate—Paget's disease of bone	0.00144	0.00144	CcSEcCtD
Duloxetine—Infection—Zoledronate—Paget's disease of bone	0.00144	0.00144	CcSEcCtD
Duloxetine—Fatigue—Risedronate—Paget's disease of bone	0.00144	0.00144	CcSEcCtD
Duloxetine—Insomnia—Pamidronate—Paget's disease of bone	0.00144	0.00144	CcSEcCtD
Duloxetine—Pain—Risedronate—Paget's disease of bone	0.00143	0.00143	CcSEcCtD
Duloxetine—Constipation—Risedronate—Paget's disease of bone	0.00143	0.00143	CcSEcCtD
Duloxetine—Shock—Zoledronate—Paget's disease of bone	0.00143	0.00143	CcSEcCtD
Duloxetine—Paraesthesia—Pamidronate—Paget's disease of bone	0.00143	0.00143	CcSEcCtD
Duloxetine—Diarrhoea—Alendronate—Paget's disease of bone	0.00143	0.00143	CcSEcCtD
Duloxetine—Nervous system disorder—Zoledronate—Paget's disease of bone	0.00142	0.00142	CcSEcCtD
Duloxetine—Thrombocytopenia—Zoledronate—Paget's disease of bone	0.00142	0.00142	CcSEcCtD
Duloxetine—Tachycardia—Zoledronate—Paget's disease of bone	0.00142	0.00142	CcSEcCtD
Duloxetine—Somnolence—Pamidronate—Paget's disease of bone	0.00141	0.00141	CcSEcCtD
Duloxetine—Skin disorder—Zoledronate—Paget's disease of bone	0.00141	0.00141	CcSEcCtD
Duloxetine—Hyperhidrosis—Zoledronate—Paget's disease of bone	0.0014	0.0014	CcSEcCtD
Duloxetine—Dyspepsia—Pamidronate—Paget's disease of bone	0.0014	0.0014	CcSEcCtD
Duloxetine—Anorexia—Zoledronate—Paget's disease of bone	0.00138	0.00138	CcSEcCtD
Duloxetine—Decreased appetite—Pamidronate—Paget's disease of bone	0.00138	0.00138	CcSEcCtD
Duloxetine—Dizziness—Alendronate—Paget's disease of bone	0.00138	0.00138	CcSEcCtD
Duloxetine—Gastrointestinal disorder—Pamidronate—Paget's disease of bone	0.00137	0.00137	CcSEcCtD
Duloxetine—Fatigue—Pamidronate—Paget's disease of bone	0.00137	0.00137	CcSEcCtD
Duloxetine—Gastrointestinal pain—Risedronate—Paget's disease of bone	0.00137	0.00137	CcSEcCtD
Duloxetine—Pain—Pamidronate—Paget's disease of bone	0.00136	0.00136	CcSEcCtD
Duloxetine—Constipation—Pamidronate—Paget's disease of bone	0.00136	0.00136	CcSEcCtD
Duloxetine—Urticaria—Risedronate—Paget's disease of bone	0.00133	0.00133	CcSEcCtD
Duloxetine—Vomiting—Alendronate—Paget's disease of bone	0.00133	0.00133	CcSEcCtD
Duloxetine—Musculoskeletal discomfort—Zoledronate—Paget's disease of bone	0.00132	0.00132	CcSEcCtD
Duloxetine—Abdominal pain—Risedronate—Paget's disease of bone	0.00132	0.00132	CcSEcCtD
Duloxetine—Body temperature increased—Risedronate—Paget's disease of bone	0.00132	0.00132	CcSEcCtD
Duloxetine—Rash—Alendronate—Paget's disease of bone	0.00131	0.00131	CcSEcCtD
Duloxetine—Insomnia—Zoledronate—Paget's disease of bone	0.00131	0.00131	CcSEcCtD
Duloxetine—Dermatitis—Alendronate—Paget's disease of bone	0.00131	0.00131	CcSEcCtD
Duloxetine—Feeling abnormal—Pamidronate—Paget's disease of bone	0.00131	0.00131	CcSEcCtD
Duloxetine—Headache—Alendronate—Paget's disease of bone	0.00131	0.00131	CcSEcCtD
Duloxetine—Paraesthesia—Zoledronate—Paget's disease of bone	0.0013	0.0013	CcSEcCtD
Duloxetine—Gastrointestinal pain—Pamidronate—Paget's disease of bone	0.0013	0.0013	CcSEcCtD
Duloxetine—Somnolence—Zoledronate—Paget's disease of bone	0.00129	0.00129	CcSEcCtD
Duloxetine—Dyspepsia—Zoledronate—Paget's disease of bone	0.00128	0.00128	CcSEcCtD
Duloxetine—Decreased appetite—Zoledronate—Paget's disease of bone	0.00126	0.00126	CcSEcCtD
Duloxetine—Abdominal pain—Pamidronate—Paget's disease of bone	0.00126	0.00126	CcSEcCtD
Duloxetine—Body temperature increased—Pamidronate—Paget's disease of bone	0.00126	0.00126	CcSEcCtD
Duloxetine—Gastrointestinal disorder—Zoledronate—Paget's disease of bone	0.00125	0.00125	CcSEcCtD
Duloxetine—Fatigue—Zoledronate—Paget's disease of bone	0.00125	0.00125	CcSEcCtD
Duloxetine—Pain—Zoledronate—Paget's disease of bone	0.00124	0.00124	CcSEcCtD
Duloxetine—Constipation—Zoledronate—Paget's disease of bone	0.00124	0.00124	CcSEcCtD
Duloxetine—Nausea—Alendronate—Paget's disease of bone	0.00124	0.00124	CcSEcCtD
Duloxetine—Hypersensitivity—Risedronate—Paget's disease of bone	0.00123	0.00123	CcSEcCtD
Duloxetine—Asthenia—Risedronate—Paget's disease of bone	0.0012	0.0012	CcSEcCtD
Duloxetine—Feeling abnormal—Zoledronate—Paget's disease of bone	0.0012	0.0012	CcSEcCtD
Duloxetine—Gastrointestinal pain—Zoledronate—Paget's disease of bone	0.00119	0.00119	CcSEcCtD
Duloxetine—Pruritus—Risedronate—Paget's disease of bone	0.00118	0.00118	CcSEcCtD
Duloxetine—Hypersensitivity—Pamidronate—Paget's disease of bone	0.00117	0.00117	CcSEcCtD
Duloxetine—Urticaria—Zoledronate—Paget's disease of bone	0.00115	0.00115	CcSEcCtD
Duloxetine—Abdominal pain—Zoledronate—Paget's disease of bone	0.00115	0.00115	CcSEcCtD
Duloxetine—Body temperature increased—Zoledronate—Paget's disease of bone	0.00115	0.00115	CcSEcCtD
Duloxetine—Diarrhoea—Risedronate—Paget's disease of bone	0.00114	0.00114	CcSEcCtD
Duloxetine—Asthenia—Pamidronate—Paget's disease of bone	0.00114	0.00114	CcSEcCtD
Duloxetine—Pruritus—Pamidronate—Paget's disease of bone	0.00112	0.00112	CcSEcCtD
Duloxetine—Dizziness—Risedronate—Paget's disease of bone	0.00111	0.00111	CcSEcCtD
Duloxetine—Diarrhoea—Pamidronate—Paget's disease of bone	0.00109	0.00109	CcSEcCtD
Duloxetine—Hypersensitivity—Zoledronate—Paget's disease of bone	0.00107	0.00107	CcSEcCtD
Duloxetine—Vomiting—Risedronate—Paget's disease of bone	0.00106	0.00106	CcSEcCtD
Duloxetine—Rash—Risedronate—Paget's disease of bone	0.00105	0.00105	CcSEcCtD
Duloxetine—Dermatitis—Risedronate—Paget's disease of bone	0.00105	0.00105	CcSEcCtD
Duloxetine—Dizziness—Pamidronate—Paget's disease of bone	0.00105	0.00105	CcSEcCtD
Duloxetine—Headache—Risedronate—Paget's disease of bone	0.00105	0.00105	CcSEcCtD
Duloxetine—Asthenia—Zoledronate—Paget's disease of bone	0.00104	0.00104	CcSEcCtD
Duloxetine—Pruritus—Zoledronate—Paget's disease of bone	0.00103	0.00103	CcSEcCtD
Duloxetine—Vomiting—Pamidronate—Paget's disease of bone	0.00101	0.00101	CcSEcCtD
Duloxetine—Rash—Pamidronate—Paget's disease of bone	0.001	0.001	CcSEcCtD
Duloxetine—Dermatitis—Pamidronate—Paget's disease of bone	0.001	0.001	CcSEcCtD
Duloxetine—Headache—Pamidronate—Paget's disease of bone	0.000996	0.000996	CcSEcCtD
Duloxetine—Diarrhoea—Zoledronate—Paget's disease of bone	0.000994	0.000994	CcSEcCtD
Duloxetine—Nausea—Risedronate—Paget's disease of bone	0.000993	0.000993	CcSEcCtD
Duloxetine—Dizziness—Zoledronate—Paget's disease of bone	0.00096	0.00096	CcSEcCtD
Duloxetine—Nausea—Pamidronate—Paget's disease of bone	0.000944	0.000944	CcSEcCtD
Duloxetine—Vomiting—Zoledronate—Paget's disease of bone	0.000923	0.000923	CcSEcCtD
Duloxetine—Rash—Zoledronate—Paget's disease of bone	0.000916	0.000916	CcSEcCtD
Duloxetine—Dermatitis—Zoledronate—Paget's disease of bone	0.000915	0.000915	CcSEcCtD
Duloxetine—Headache—Zoledronate—Paget's disease of bone	0.00091	0.00091	CcSEcCtD
Duloxetine—Nausea—Zoledronate—Paget's disease of bone	0.000863	0.000863	CcSEcCtD
